We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current DNTH market cap is 316.36M. The company's latest EPS is USD -2.9394 and P/E is -7.28.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 2.37M |
| Operating Income | -17.25M | -21.73M | -32.13M | -7.38M | -15.63M |
| Net Income | -16.06M | -20.18M | -29.17M | -3.28M | -538k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 2.83M |
| Operating Income | -82.97M | -78.7M | -74.69M | -80.9M | -48.17M |
| Net Income | -76.77M | -74.94M | -71.14M | -76.46M | -43.56M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 164.12M | 146.65M | 83.44M | 78.64M | 192.46M |
| Total Liabilities | 40.1M | 40.69M | 5.98M | 4.03M | 14.08M |
| Total Equity | 124.03M | 105.96M | 77.46M | 74.6M | 178.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 161.51M | 161.62M | 189.93M | 146.65M | 179.41M |
| Total Liabilities | 20.32M | 17.71M | 17.26M | 40.69M | 10.54M |
| Total Equity | 141.19M | 143.91M | 172.67M | 105.96M | 168.87M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -50.4M | -67.09M | -35.6M | -42.14M | -25.01M |
| Investing | -25.03M | -9.81M | 26.5M | 45.37M | 28.49M |
| Financing | 2.81M | 2.88M | N/A | N/A | 138.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -57.1M | -64.02M | -59.53M | -67.09M | -36.86M |
| Investing | 1.53M | -10.64M | 43.43M | -9.81M | 20.25M |
| Financing | 62.3M | 67.74M | 89.6M | 2.88M | 133.57M |
| Market Cap | 316.36M |
| Price to Earnings Ratio | -7.28 |
| Price to Sales Ratio | 112.17 |
| Price to Cash Ratio | 2.4 |
| Price to Book Ratio | 1.88 |
| Dividend Yield | - |
| Shares Outstanding | 14.82M |
| Average Volume (1 week) | 158.07k |
| Average Volume (1 Month) | 177.08k |
| 52 Week Change | 105.29% |
| 52 Week High | 33.77 |
| 52 Week Low | 6.58 |
| Spread (Intraday) | 19.96 (89.51%) |
| Company Name | Dianthus Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.magentatx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
